#Softox $SOFTX nordic #biofilm medtech with US defence grant

SoftOx Solutions AS is a Scandinavian medtech company, founded in 2012, listed at Euronext Growth with new ticker SOFTX. After years of research and product development with leading Nordic research institutions, SoftOx has developed a non-toxic and highly efficient antiseptic technology, which eradicates and prevents biofilm infections and is fully virucidal.

THESE PRODUCTS ARE CURRENTLY UNDER DEVELOPMENT

Human Wound & Infection Treatments

SoftOx is developing a range of products that can be classified as either medical devices or medicinal products (drugs) for human use. Collectively, the R&D efforts are focused on prevention and eradication of serious infections. Such infections are not limited to pathogenic bacteria, but may also include viral and fungal infections. The current product candidates are either in the clinical or late stage preclincal (animal testing) phase.

SoftOx Wound Irrigation Solutions (medical device) for acute and chronic wounds, to both prevent and treat infections (including biofilms).
SoftOx Anti-infectives are products aimed to actively treat and remove topical infections in wounded and mucosal tissues, such as those caused by biofilms, AMR microbes, viruses and fungi.

Beyond Technical AnalysisChart PatternsmedtechTrend Analysis

Also on:

Related publications

Disclaimer